NCT05784155View on ClinicalTrials.gov

To Evaluate the PK, PD, Safety and Drug Tolerance of JW0302 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 10, 2023

Primary Completion Date

June 9, 2023

Study Completion Date

June 26, 2023

Conditions

Healthy

Interventions

DRUG

Test Drug(JW0302) or Reference Drug(C2206)

"Test Drug: single administration of JW0302 Reference Drug: single administration of C2206~Tablet, Oral, QD for 1 Days, Washout period is more than 14 days after administration"

Trial Locations (1)

Unknown

Clinical Trial Center, Seoul National University Hospital, Seoul